Human genetic determinants of dengue virus susceptibility

Microbes and Infection

Volumn 11, Issue 2, 2009, Pages 143-156

  Coffey, Lark L ^a   Mertens, Eva ^a   Brehin, Anne Claire ^a   Fernandez Garcia, Maria Dolores ^a   Amara, Ali ^a   Després, Philippe ^a   Sakuntabhai, Anavaj ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Arbovirus; Dengue hemorrhagic fever; Dengue virus; Human genetic susceptibility; Single nucleotide polymorphism

Indexed keywords

BIOLOGICAL MARKER; FC RECEPTOR; LEUKOCYTE ANTIGEN; THROMBOCYTE ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D RECEPTOR;

ALLELE; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; BLEEDING; BLOOD GROUP TYPING; CYTOKINE PRODUCTION; DENGUE; DENGUE VIRUS; DISEASE PREDISPOSITION; DISEASE SEVERITY; ETHNICITY; FLUID THERAPY; GENETIC ANALYSIS; HEMORRHAGIC FEVER; HEMORRHAGIC SHOCK; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; MORBIDITY; NUTRITIONAL STATUS; PATHOGENESIS; PRIORITY JOURNAL; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL GENETICS;

DENGUE; DENGUE VIRUS; DISEASE SUSCEPTIBILITY; HOST-PARASITE INTERACTIONS; HUMANS;

ARBOVIRUS; DENGUE VIRUS;

EID: 61449187250     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2008.12.006     Document Type: Short Survey

References (69)

1. Gubler D.J. Dengue/dengue haemorrhagic fever: history and current status. Novartis Found. Symp. (2006) 3-16 (discussion: 16-22, 71-13, 251-253)
2. WHO. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control. second ed. (1997), World Health Organization, Geneva
3. Phuong C.X., Nhan N.T., Kneen R., Thuy P.T., van Thien C., Nga N.T., Thuy T.T., Solomon T., Stepniewska K., and Wills B. Clinical diagnosis and assessment of severity of confirmed dengue infections in Vietnamese children: is the world health organization classification system helpful?. Am. J. Trop. Med. Hyg. 70 (2004) 172-179
4. Imrie A., Meeks J., Gurary A., Sukhbaatar M., Truong T.T., Cropp C.B., and Effler P. Antibody to dengue 1 detected more than 60 years after infection. Viral Immunol. 20 (2007) 672-675
5. Schneider B.S., and Higgs S. The enhancement of arbovirus transmission and disease by mosquito saliva is associated with modulation of the host immune response. Trans. R. Soc. Trop. Med. Hyg. 102 (2008) 400-408
6. Simmons C.P., Popper S., Dolocek C., Chau T.N., Griffiths M., Dung N.T., Long T.H., Hoang D.M., Chau N.V., Thao le T.T., Hien T.T., Relman D.A., and Farrar J. Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever. J. Infect. Dis. 195 (2007) 1097-1107
7. Libraty D.H., Young P.R., Pickering D., Endy T.P., Kalayanarooj S., Green S., Vaughn D.W., Nisalak A., Ennis F.A., and Rothman A.L. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J. Infect. Dis. 186 (2002) 1165-1168
8. Rico-Hesse R. Dengue virus evolution and virulence models. Clin. Infect. Dis. 44 (2007) 1462-1466
9. Gubler D.J., Reed D., Rosen L., and Hitchcock Jr. J.R. Epidemiologic, clinical, and virologic observations on dengue in the Kingdom of Tonga. Am. J. Trop. Med. Hyg. 27 (1978) 581-589
10. Watts D.M., Porter K.R., Putvatana P., Vasquez B., Calampa C., Hayes C.G., and Halstead S.B. Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever. Lancet 354 (1999) 1431-1434
11. Reed D., Maguire T., and Mataika J. Type 1 dengue with hemorrhagic disease in Fiji: epidemiologic findings. Am. J. Trop. Med. Hyg. 26 (1977) 784-791
12. Scott R.M., Nimmannitya S., Bancroft W.H., and Mansuwan P. Shock syndrome in primary dengue infections. Am. J. Trop. Med. Hyg. 25 (1976) 866-874
13. Halstead S.B., Streit T.G., Lafontant J.G., Putvatana R., Russell K., Sun W., Kanesa-Thasan N., Hayes C.G., and Watts D.M. Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. Am. J. Trop. Med. Hyg. 65 (2001) 180-183
14. Kalayanarooj S., Gibbons R.V., Vaughn D., Green S., Nisalak A., Jarman R.G., Mammen Jr. M.P., and Perng G.C. Blood group AB is associated with increased risk for severe dengue disease in secondary infections. J. Infect. Dis. 195 (2007) 1014-1017
15. Fink J., Gu F., and Vasudevan S.G. Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever. Rev. Med. Virol. 16 (2006) 263-275
16. Tassaneetrithep B., Burgess T.H., Granelli-Piperno A., Trumpfheller C., Finke J., Sun W., Eller M.A., Pattanapanyasat K., Sarasombath S., Birx D.L., Steinman R.M., Schlesinger S., and Marovich M.A. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 197 (2003) 823-829
17. Anderson R. Manipulation of cell surface macromolecules by flaviviruses. Adv. Virus Res. 59 (2003) 229-274
18. Libraty D.H., Pichyangkul S., Ajariyakhajorn C., Endy T.P., and Ennis F.A. Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J. Virol. 75 (2001) 3501-3508
19. Wu S.J., Grouard-Vogel G., Sun W., Mascola J.R., Brachtel E., Putvatana R., Louder M.K., Filgueira L., Marovich M.A., Wong H.K., Blauvelt A., Murphy G.S., Robb M.L., Innes B.L., Birx D.L., Hayes C.G., and Frankel S.S. Human skin langerhans cells are targets of dengue virus infection. Nat. Med. 6 (2000) 816-820
20. Jessie K., Fong M.Y., Devi S., Lam S.K., and Wong K.T. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J. Infect. Dis. 189 (2004) 1411-1418
21. Chen S.T., Lin Y.L., Huang M.T., Wu M.F., Cheng S.C., Lei H.Y., Lee C.K., Chiou T.W., Wong C.H., and Hsieh S.L. CLEC5A is critical for dengue-virus-induced lethal disease. Nature 453 (2008) 672-676
22. Halstead S.B. Neutralization and antibody-dependent enhancement of dengue viruses. Adv. Virus Res. 60 (2003) 421-467
23. Koraka P., Suharti C., Setiati T.E., Mairuhu A.T., Van Gorp E., Hack C.E., Juffrie M., Sutaryo J., Van Der Meer G.M., Groen J., and Osterhaus A.D. Kinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection. J. Clin. Microbiol. 39 (2001) 4332-4338
24. Koraka P., Murgue B., Deparis X., Setiati T.E., Suharti C., van Gorp E.C., Hack C.E., Osterhaus A.D., and Groen J. Elevated levels of total and dengue virus-specific immunoglobulin E in patients with varying disease severity. J. Med. Virol. 70 (2003) 91-98
25. Vaughn D.W., Green S., Kalayanarooj S., Innis B.L., Nimmannitya S., Suntayakorn S., Endy T.P., Raengsakulrach B., Rothman A.L., Ennis F.A., and Nisalak A. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 181 (2000) 2-9
26. Avirutnan P., Punyadee N., Noisakran S., Komoltri C., Thiemmeca S., Auethavornanan K., Jairungsri A., Kanlaya R., Tangthawornchaikul N., Puttikhunt C., Pattanakitsakul S.N., Yenchitsomanus P.T., Mongkolsapaya J., Kasinrerk W., Sittisombut N., Husmann M., Blettner M., Vasanawathana S., Bhakdi S., and Malasit P. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J. Infect. Dis. 193 (2006) 1078-1088
27. Shresta S., Kyle J.L., Snider H.M., Basavapatna M., Beatty P.R., and Harris E. Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J. Virol. 78 (2004) 2701-2710
28. Fink J., Gu F., Ling L., Tolfvenstam T., Olfat F., Chin K.C., Aw P., George J., Kuznetsov V.A., Schreiber M., Vasudevan S.G., and Hibberd M.L. Host gene expression profiling of dengue virus infection in cell lines and patients. PLoS Negl. Trop. Dis. 1 (2007) e86
29. Sariol C.A., Munoz-Jordan J.L., Abel K., Rosado L.C., Pantoja P., Giavedoni L., Rodriguez I.V., White L.J., Martinez M., Arana T., and Kraiselburd E.N. Transcriptional activation of interferon-stimulated genes but not of cytokine genes after primary infection of rhesus macaques with dengue virus type 1. Clin. Vaccine Immunol. 14 (2007) 756-766
30. Rothman A.L. Immunology and immunopathogenesis of dengue disease. Adv. Virus Res. 60 (2003) 397-419
31. Kurane I., Innis B.L., Nimmannitya S., Nisalak A., Meager A., Janus J., and Ennis F.A. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J. Clin. Invest. 88 (1991) 1473-1480
32. Green S., Vaughn D.W., Kalayanarooj S., Nimmannitya S., Suntayakorn S., Nisalak A., Lew R., Innis B.L., Kurane I., Rothman A.L., and Ennis F.A. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J. Infect. Dis. 179 (1999) 755-762
33. Lee Y.R., Liu M.T., Lei H.Y., Liu C.C., Wu J.M., Tung Y.C., Lin Y.S., Yeh T.M., Chen S.H., and Liu H.S. MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells. J. Gen. Virol. 87 (2006) 3623-3630
34. Mongkolsapaya J., Dejnirattisai W., Xu X.N., Vasanawathana S., Tangthawornchaikul N., Chairunsri A., Sawasdivorn S., Duangchinda T., Dong T., Rowland-Jones S., Yenchitsomanus P.T., McMichael A., Malasit P., and Screaton G. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med. 9 (2003) 921-927
35. Hung T.N., Lei H.Y., Nguyen T.L., Lin Y.S., Huang K.J., Le B.L., Lin C.F., Yeh T.M., Do Q.H., Vu T.Q., Chen L.C., Huang J.H., Lam T.M., Liu C.C., and Halstead S.B. Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J. Infect. Dis. 189 (2004) 221-232
36. Mairuhu A.T., Mac Gillavry M.R., Setiati T.E., Soemantri A., Ten Cate H., Brandjes D.P., and van Gorp E.C. Is clinical outcome of dengue-virus infections influenced by coagulation and fibrinolysis? A critical review of the evidence. Lancet Infect. Dis. 3 (2003) 33-41
37. Mairuhu A.T., Setiati T.E., Koraka P., Hack C.E., Leyte A., Faradz S.M., ten Cate H., Brandjes D.P., Osterhaus A.D., Reitsma P.H., and van Gorp E.C. Increased PAI-1 plasma levels and risk of death from dengue: no association with the 4G/5G promoter polymorphism. Thromb. J. 3 (2005) 17
38. Soundravally R., and Hoti S.L. Significance of transporter associated with antigen processing 2 (TAP2) gene polymorphisms in susceptibility to dengue viral infection. J. Clin. Immunol. (2007)
39. Momburg F., Mullbacher A., and Lobigs M. Modulation of transporter associated with antigen processing (TAP)-mediated peptide import into the endoplasmic reticulum by flavivirus infection. J. Virol. 75 (2001) 5663-5671
40. Rico-Hesse R., Harrison L.M., Salas R.A., Tovar D., Nisalak A., Ramos C., Boshell J., de Mesa M.T., Nogueira R.M., and da Rosa A.T. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 230 (1997) 244-251
41. Kouri G., Mas P., Guzman M.G., Soler M., Goyenechea A., and Morier L. Dengue hemorrhagic fever in Cuba, 1981: rapid diagnosis of the etiologic agent. Bull. Pan Am. Health Organ. 17 (1983) 126-132
42. Cologna R., Armstrong P.M., and Rico-Hesse R. Selection for virulent dengue viruses occurs in humans and mosquitoes. J. Virol. 79 (2005) 853-859
43. Anderson J.R., and Rico-Hesse R. Aedes aegypti vectorial capacity is determined by the infecting genotype of dengue virus. Am. J. Trop. Med. Hyg. 75 (2006) 886-892
44. Shurtleff A.C., Beasley D.W., Chen J.J., Ni H., Suderman M.T., Wang H., Xu R., Wang E., Weaver S.C., Watts D.M., Russell K.L., and Barrett A.D. Genetic variation in the 3' non-coding region of dengue viruses. Virology 281 (2001) 75-87
45. Kochel T.J., Watts D.M., Halstead S.B., Hayes C.G., Espinoza A., Felices V., Caceda R., Bautista C.T., Montoya Y., Douglas S., and Russell K.L. Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever. Lancet 360 (2002) 310-312
46. Hammond S.N., Balmaseda A., Perez L., Tellez Y., Saborio S.I., Mercado J.C., Videa E., Rodriguez Y., Perez M.A., Cuadra R., Solano S., Rocha J., Idiaquez W., Gonzalez A., and Harris E. Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua. Am. J. Trop. Med. Hyg. 73 (2005) 1063-1070
47. Tanner L., Schreiber M., Low J.G., Ong A., Tolfvenstam T., Lai Y.L., Ng L.C., Leo Y.S., Thi Puong L., Vasudevan S.G., Simmons C.P., Hibberd M.L., and Ooi E.E. Decision tree algorithms predict the diagnosis and outcome of dengue fever in the early phase of illness. PLoS Negl. Trop. Dis. 2 (2008) e196
48. Shekhar K.C., and Huat O.L. Epidemiology of dengue/dengue hemorrhagic fever in Malaysia-a retrospective epidemiological study. 1973-1987. Part II: dengue fever (DF). Asia Pac. J. Public Health 6 (1992) 126-133
49. Shekhar K.C., and Huat O.L. Epidemiology of dengue/dengue hemorrhagic fever in Malaysia-a retrospective epidemiological study 1973-1987. Part I: dengue hemorrhagic fever (DHF). Asia Pac. J. Public Health 6 (1992) 15-25
50. Bravo J.R., Guzman M.G., and Kouri G.P. Why dengue haemorrhagic fever in Cuba? 1. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). Trans. R. Soc. Trop. Med. Hyg. 81 (1987) 816-820
51. Guzman M.G., Kouri G.P., Bravo J., Soler M., Vazquez S., and Morier L. Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am. J. Trop. Med. Hyg. 42 (1990) 179-184
52. Gibbons R.V., Kalanarooj S., Jarman R.G., Nisalak A., Vaughn D.W., Endy T.P., Mammen Jr. M.P., and Srikiatkhachorn A. Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences. Am. J. Trop. Med. Hyg. 77 (2007) 910-913
53. Sangkawibha N., Rojanasuphot S., Ahandrik S., Viriyapongse S., Jatanasen S., Salitul V., Phanthumachinda B., and Halstead S.B. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am. J. Epidemiol. 120 (1984) 653-669
54. Russell P.K., Yuill T.M., Nisalak A., Udomsakdi S., Gould D.J., and Winter P.E. An insular outbreak of dengue hemorrhagic fever. II. Virologic and serologic studies. Am. J. Trop. Med. Hyg. 17 (1968) 600-608
55. Nguyen T.H., Nguyen T.L., Lei H.Y., Lin Y.S., Le B.L., Huang K.J., Lin C.F., Do Q.H., Vu T.Q., Lam T.M., Yeh T.M., Huang J.H., Liu C.C., and Halstead S.B. Association between sex, nutritional status, severity of dengue hemorrhagic fever, and immune status in infants with dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 72 (2005) 370-374
56. Pichainarong N., Mongkalangoon N., Kalayanarooj S., and Chaveepojnkamjorn W. Relationship between body size and severity of dengue hemorrhagic fever among children aged 0-14 years. Southeast Asian J. Trop. Med. Public Health 37 (2006) 283-288
57. Chiewsilp P., Scott R.M., and Bhamarapravati N. Histocompatibility antigens and dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 30 (1981) 1100-1105
58. Paradoa Perez M.L., Trujillo Y., and Basanta P. Association of dengue hemorrhagic fever with the HLA system. Haematologia (Budap) 20 (1987) 83-87
59. Stephens H.A., Klaythong R., Sirikong M., Vaughn D.W., Green S., Kalayanarooj S., Endy T.P., Libraty D.H., Nisalak A., Innis B.L., Rothman A.L., Ennis F.A., and Chandanayingyong D. HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens 60 (2002) 309-318
60. Loke H., Bethell D.B., Phuong C.X., Dung M., Schneider J., White N.J., Day N.P., Farrar J., and Hill A.V. Strong HLA class I-restricted T cell responses in dengue hemorrhagic fever: a double-edged sword?. J. Infect. Dis. 184 (2001) 1369-1373
61. Lan N.T., Kikuchi M., Huong V.T., Ha do Q., Thuy T.T., Tham V.D., Tuan H.M., Tuong V.V., Nga C.T., Van Dat T., Oyama T., Morita K., Yasunami M., and Hirayama K. Protective and enhancing HLA alleles, HLA-DRB1*0901 and HLA-A*24, for severe forms of dengue virus infection, dengue hemorrhagic fever and dengue shock syndrome. PLoS Negl. Trop. Dis. 2 (2008) e304
62. Sierra B., Alegre R., Perez A.B., Garcia G., Sturn-Ramirez K., Obasanjo O., Aguirre E., Alvarez M., Rodriguez-Roche R., Valdes L., Kanki P., and Guzman M.G. HLA-A, -B, -C, and -DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: advantages of the Cuban population for HLA studies of dengue virus infection. Hum. Immunol. 68 (2007) 531-540
63. Polizel J.R., Bueno D., Visentainer J.E., Sell A.M., Borelli S.D., Tsuneto L.T., Dalalio M.M., Coimbra M.T., and Moliterno R.A. Association of human leukocyte antigen DQ1 and dengue fever in a white Southern Brazilian population. Mem. Inst. Oswaldo Cruz 99 (2004) 559-562
64. LaFleur C., Granados J., Vargas-Alarcon G., Ruiz-Morales J., Villarreal-Garza C., Higuera L., Hernandez-Pacheco G., Cutino-Moguel T., Rangel H., Figueroa R., Acosta M., Lazcano E., and Ramos C. HLA-DR antigen frequencies in Mexican patients with dengue virus infection: HLA-DR4 as a possible genetic resistance factor for dengue hemorrhagic fever. Hum. Immunol. 63 (2002) 1039-1044
65. Juffrie M., Meer G.M., Hack C.E., Haasnoot K., SutaryoVeerman A.J., and Thijs L.G. Inflammatory mediators in dengue virus infection in children: interleukin-6 and its relation to C-reactive protein and secretory phospholipase A2. Am. J. Trop. Med. Hyg. 65 (2001) 70-75
66. Azeredo E.L., Zagne S.M., Santiago M.A., Gouvea A.S., Santana A.A., Neves-Souza P.C., Nogueira R.M., Miagostovich M.P., and Kubelka C.F. Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever. Immunobiology 204 (2001) 494-507
67. Loke H., Bethell D., Phuong C.X., Day N., White N., Farrar J., and Hill A. Susceptibility to dengue hemorrhagic fever in Vietnam: evidence of an association with variation in the vitamin D receptor and Fc gamma receptor IIa genes. Am. J. Trop. Med. Hyg. 67 (2002) 102-106
68. Fernandez-Mestre M.T., Gendzekhadze K., Rivas-Vetencourt P., and Layrisse Z. TNF-alpha-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients. Tissue Antigens 64 (2004) 469-472
69. Sakuntabhai A., Turbpaiboon C., Casademont I., Chuansumrit A., Lowhnoo T., Kajaste-Rudnitski A., Kalayanarooj S.M., Tangnararatchakit K., Tangthawornchaikul N., Vasanawathana S., Chaiyaratana W., Yenchitsomanus P.T., Suriyaphol P., Avirutnan P., Chokephaibulkit K., Matsuda F., Yoksan S., Jacob Y., Lathrop G.M., Malasit P., Despres P., and Julier C. A variant in the CD209 promoter is associated with severity of dengue disease. Nat. Genet. 37 (2005) 507-513